TERMINATEDPhase 2/3

Gent for Pharyngeal Gonorrhea (GC)

Gentamicin for Pharyngeal Gonorrhea - A Demonstration Study

NCT03632109•University of Washington

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Pharyngeal Gonococcal Infection

Interventions

gentamicin 360mg IM

Locations

1

United States

Locations (1)

Public Health -- Seattle & King County STD Clinic

Seattle, Washington, United States

Key Dates

Start Date

September 17, 2018

Primary Completion Date

March 12, 2019

Completion Date

March 12, 2019

Last Updated

August 10, 2020

Sponsors

Lead Sponsor

University of Washington

Collaborators

National Institute of Allergy and Infectious Diseases (NIAID)

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 10, 2020Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions